Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/4YXvAAddkk0/227142.php
Wednesday 1 June 2011
European Medicines Agency And Heads Of Medicines Agencies Propose Measures To Make Information In Application Dossiers More Transparent
The European Medicines Agency and the Heads of Medicines Agencies (HMA) have released a guidance document on the identification of commercially confidential information and protection of personal data within the structure of the marketing-authorisation dossier for public consultation. The draft document, which is open for comment until 1 September 2011, outlines the types of information included in marketing-authorisation applications that can be released following a request for access to documents, once a marketing authorisation has been granted...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment